B7-H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Zhang, Jie ^a   Zhang, Mingyan ^a   Jiang, Wei ^a   Wang, Lihong ^a   Fu, Zhenkun ^a   Li, Dalin ^a   Pang, Da ^a   Li, Dianjun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; ESTROGEN RECEPTOR; GUANINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR B7 H4; UNCLASSIFIED DRUG; B7 ANTIGEN; VTCN1 PROTEIN, HUMAN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POPULATION RESEARCH; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME; ASIAN; BREAST TUMOR; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ANTIGENS, CD80; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS;

EID: 71049131850     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-394     Document Type: Article

References (27)

1. Inman BA, Frigola X, Dong H, Kwon ED. Costimulation, coinhibition and cancer. Curr Cancer Drug Targets 2007, 7(1):15-30. 10.2174/156800907780006878, 17305475.
2. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004, 4(5):336-347. 10.1038/nri1349, 15122199.
3. Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, Tamura H, Chapoval AI, Flies DB, Bajorath J, Chen L. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003, 18(6):849-861. 10.1016/S1074-7613(03)00152-3, 12818165.
4. Prasad DVR, Richards S, Mai XM, Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003, 18(6):863-873. 10.1016/S1074-7613(03)00147-X, 12818166.
5. Zang XX, Loke P, Kim J, Murphy K, Waitz R, Allison JP. B7x: A widely expressed B7 family member that inhibits T cell activation. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(18):10388-10392. 193571, 12920180, 10.1073/pnas.1434299100.
6. Tringler B, Zhuo S, Pilkington G, Torkko KC, Singh M, Lucia MS, Heinz DE, Papkoff J, Shroyer KR. B7-h4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res 2005, 11(5):1842-1848. 10.1158/1078-0432.CCR-04-1658, 15756008.
7. Salceda S, Tang T, Kmet M, Munteanu A, Ghosh M, Macina R, Liu W, Pilkington G, Papkoff J. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res 2005, 306(1):128-141. 10.1016/j.yexcr.2005.01.018, 15878339.
8. Choi IH, Zhu G, Sica GL, Strome SE, Cheville JC, Lau JS, Zhu Y, Flies DB, Tamada K, Chen L. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 2003, 171(9):4650-4654.
9. Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK, Wang X. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006, 53(2):143-151. 10.1016/j.lungcan.2006.05.012, 16782226.
10. Krambeck AE, Thompson RH, Dong H, Lohse CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC, Kwon ED. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci USA 2006, 103(27):10391-10396. 1502468, 16798883, 10.1073/pnas.0600937103.
11. Mugler KC, Singh M, Tringler B, Torkko KC, Liu W, Papkoff J, Shroyer KR. B7-h4 expression in a range of breast pathology: correlation with tumor T-cell infiltration. Appl Immunohistochem Mol Morphol 2007, 15(4):363-370. 10.1097/01.pai.0000213159.79557.71, 18091377.
12. Mignone F, Gissi C, Liuni S, Pesole G. Untranslated regions of mRNAs. Genome Biol 2002, 3(3):REVIEWS0004. 139023, 11897027, 10.1186/gb-2002-3-3-reviews0004.
13. Nott A, Meislin SH, Moore MJ. A quantitative analysis of intron effects on mammalian gene expression. RNA 2003, 9(5):607-617. 1370426, 12702819, 10.1261/rna.5250403.
14. Gazave E, Marques-Bonet T, Fernando O, Charlesworth B, Navarro A. Patterns and rates of intron divergence between humans and chimpanzees. Genome Biol 2007, 8(2):R21. 1852421, 17309804, 10.1186/gb-2007-8-2-r21.
15. Ma H, Hu Z, Wang H, Jin G, Wang Y, Sun W, Chen D, Tian T, Jin L, Wei Q. ERCC6/CSB gene polymorphisms and lung cancer risk. Cancer Lett 2009, 273(1):172-176. 10.1016/j.canlet.2008.08.002, 18789574.
16. Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet 2005, 42(10):737-748. 1735933, 16199547, 10.1136/jmg.2004.029538.
17. Mathews DH, Turner DH, Zuker M. RNA secondary structure prediction. Curr Protoc Nucleic Acid Chem 2007, Chapter 11(Unit 11):12.
18. Shastry BS. SNP alleles in human disease and evolution. J Hum Genet 2002, 47(11):561-566. 10.1007/s100380200086, 12436191.
19. Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, Dehaghani AS. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat 2004, 86(1):1-7. 10.1023/B:BREA.0000032918.89120.8e, 15218356.
20. Lee SH, Lee YA, Woo DH, Song R, Park EK, Ryu MH, Kim YH, Kim KS, Hong SJ, Yoo MC. Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population. Arthritis Res Ther 2006, 8(6):R163. 1794506, 17064404, 10.1186/ar2071.
21. Lin SC, Kuo CC, Chan CH. Association of a BTLA gene polymorphism with the risk of rheumatoid arthritis. J Biomed Sci 2006, 13(6):853-860. 10.1007/s11373-006-9113-7, 17024343.
22. Chen JM, Ferec C, Cooper DN. A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet 2006, 120(1):1-21. 10.1007/s00439-006-0180-7, 16645853.
23. Majewski J, Ott J. Distribution and characterization of regulatory elements in the human genome. Genome Res 2002, 12(12):1827-1836. 187578, 12466286, 10.1101/gr.606402.
24. Braddock M, Muckenthaler M, White MR, Thorburn AM, Sommerville J, Kingsman AJ, Kingsman SM. Intron-less RNA injected into the nucleus of Xenopus oocytes accesses a regulated translation control pathway. Nucleic Acids Res 1994, 22(24):5255-5264. 332069, 7816614, 10.1093/nar/22.24.5255.
25. Balvay L, Libri D, Fiszman MY. Pre-mRNA secondary structure and the regulation of splicing. Bioessays 1993, 15(3):165-169. 10.1002/bies.950150304, 8489523.
26. Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 2008, 107(3):309-330. 2217620, 17377838, 10.1007/s10549-007-9556-1.
27. Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol 2007, 25(30):4772-4778. 10.1200/JCO.2007.12.2747, 17876012.